Join the Network
← Insitro
Insitro · Hiring

Full Stack Software Engineer, Lab Platform (LIMS)

South San Francisco, CAFull Time

The Opportunity

insitro is a physical AI company dedicated to unlocking causal human biology and accelerating the delivery of better medicines to patients. Our unique Virtual Human™ platform identifies novel, high-impact genetic intervention points, which our TherML™ platform translates into therapeutics—whether small molecules, biologics, or oligos. With multiple programs in metabolic disease and neuroscience advancing toward the clinic, and our first IND submission slated for the second half of this year, we are at a pivotal inflection point.

To enable that mission, we need a software layer that ties together the scientific, automation, and machine learning platforms — that's our Lab Platform: a harness for science, built as an agentic workflow system that lets scientists drive the lab through an agent. Our bar is that everything in the lab should be agentically accessible (any action a scientist can take, an agent can take), agentically legible (agents understand what the data means in insitro's context, not just how to fetch it), and humanly verifiable (a scientist can always check what an agent did and why). This is real robotics, workflow automation, and applied agent tooling — and your users are in the building with you.

You'll work across the stack — front end, backend, and the integrations that reach into instruments, Benchling, and agent runtimes — partnering closely with our machine learning, automation, and biology teams. Based in South San Francisco, this role reports directly to Senior Manager, Software Engineering and offers an in-person hybrid schedule of three days per week. We'll bring you up to speed in the domain of drug development and back your ideas with real trust and mentorship along the way.

Responsibilities

Full-Stack Ownership

Agentic Tooling & Experimentation

Cross-Functional Partnership

About You

Experience & Qualifications

Core Competencies

Preferred Qualifications

Compensation & Benefits at insitro

Our target starting salary for successful US-based applicants for this role is $111,000 - $140,000. To determine starting pay, we consider multiple job-related factors including a candidate's skills, education and experience, market demand, business needs, and internal parity. We may also adjust this range in the future based on market data.

This role is eligible for participation in our Annual Performance Bonus Plan (based on company targets by role level and annual company performance) and our Equity Incentive Plan, subject to the terms of those plans and associated policies.

In addition, insitro also provides our employees:

insitro is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.

We believe diversity, equity, and inclusion need to be at the foundation of our culture. We work hard to bring together diverse teams–grounded in a wide range of expertise and life experiences–and work even harder to ensure those teams thrive in inclusive, growth-oriented environments supported by equitable company and team practices. All candidates can expect equitable treatment, respect, and fairness throughout the interview process.

#LI-Hybrid

Please be aware of recruitment scams: we never request payments, all recruitment communications are from @insitro.com, and if in doubt, contact us at info@insitro.com. 

About insitro

insitro is a drug discovery and development company using machine learning (ML) and data at scale to decode biology for transformative medicines. At the core of insitro’s approach is the convergence of in-house generated multi-modal cellular data and high-content phenotypic human cohort data. We rely on these data to develop ML-driven, predictive disease models that uncover underlying biologic state and elucidate critical drivers of disease. These powerful models rely on extensive biological and computational infrastructure and allow insitro to advance novel targets and patient biomarkers, design therapeutics and inform clinical strategy. insitro is advancing a wholly owned and partnered pipeline of insights and therapeutics in neuroscience and metabolism. Since launching in 2018, insitro has raised over $700 million from top tech, biotech and crossover investors, and from collaborations with pharmaceutical partners. For more information on insitro, please visit www.insitro.com.

Interested in This Role?

Apply at Insitro

You'll head to Insitro's own careers page.